Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 7Unknown 4Recruiting 4Withdrawn 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Fistula 1Duodenal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 438Carboplatin 322Nivolumab 286Cyclophosphamide 280Specimen Handling 257Cisplatin 252Paclitaxel 249Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 167atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 113Oxaliplatin 112Etoposide 111Radiosurgery 109venetoclax 108Fluorouracil 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Anti-Bacterial Agents × Clear all
NCT03631173 2026-04-28

MINIMUM

Oslo University Hospital

Phase NA Active not recruiting
201 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

NCT04281667 2022-11-17

MOBILE2

Helsinki University Central Hospital

Phase 4 Active not recruiting
604 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡